GCPL Q1 FY27 Results: 11.5% profit growth, stock drops 2.8% on margin concerns

The company's India business delivered robust performance with domestic volume growth of 9% for the June quarter, which turned out to be at the higher end of the CNBC-TV18 poll estimate of 8% to 9%. This strong volume performance indicates healthy consumer demand across key product categories, with the home care segment expected to grow around 12% and the personal care business likely to post healthy growth of 4-7% during the quarter. The company is expanding its fast-moving categories, and their salience has increased from 15% last year to 17%, with this trend expected to continue sequentially as GCPL adds more products in new categories. The Home Care business grew 12% during the quarter, supported by broad-based strength across categories, while the Personal Care segment recorded 11% growth, led by healthy performance across key categories including strong recovery in soaps and continued leadership in handwash segments. On a standalone basis, GCPL's underlying volume grew 7% with EBITDA growing 10% to ₹548 crore.

GCPL's international operations continued their strong performance during the quarter, with revenue from international markets estimated to grow around 15% in rupee terms. The Indonesia business is expected to report around 15% volume growth as competitive pressure in the market continues to ease, while the GAUM business, which includes Africa, the USA and the Middle East, is also expected to remain strong with volume growth of around 47% yearly during the quarter. The exceptional performance in Africa was driven by strong FMCG expansion across multiple countries and categories, contributing significantly to the company's overall growth momentum. The revenue from the Africa market was up 47% to ₹1,006.13 crore with UVG of 17% and EBITDA growth of 42%, led by doubling media spends and continued strong performance in Hair Fashion across key markets. The revenue from the others segment, including Latin America and other markets, was up 17.36% to ₹258.32 crore. For the GUAM markets, CFO Aasif Malbari noted that the company is now building in new categories, and it's a large multi-decade opportunity in terms of building in categories, they definitely see this business performing at elevated levels going forward.

Despite strong revenue and profit growth, EBITDA margin remained under pressure at 19%, down from 19.4% in the year-ago quarter, as higher commodity prices continue to increase input costs. The cost of raw materials increased 16.8% YoY to ₹1,728 crore, compared with ₹1,480 crore in the corresponding quarter last year, while advertising and publicity expenses rose 12.5% to ₹306 crore from ₹272 crore a year ago. Gross margin declined sharply by 261 basis points compared to the year-ago period. Despite these increases in operating costs, EBITDA growth remained strong at 15.7% during the quarter, indicating the company's ability to manage cost pressures effectively despite the challenging input cost environment. Total expenses of GCPL were at ₹3,585.24 crore, up 18.6% in the first quarter of FY27. CFO Aasif Malbari noted that commodity prices at current levels should limit further price increases, with a large portion of price increases already passed on to consumers. Managing Director and CEO Sudhir Sitapati had earlier noted that the operating environment remained challenging due to elevated input costs and volatility in crude and other commodities amid geopolitical developments.

Godrej Consumer Products Ltd. shares plunged 2.8% to ₹1,020.70 on the NSE on Monday, after the company's operating margins took a hit in the first quarter of financial year 2027. The stock pared some losses to trade 2.57% lower at ₹1,023 apiece as of 10:40 a.m., as against a 0.13% advance in the benchmark Nifty index. Despite margin pressures, brokerages remain largely bullish on GCPL's prospects. Macquarie has maintained an outperform rating with a Target Price of ₹1,250, noting that market share gains in insecticides and improving international momentum remain key positives, while near-term India margin pressure and weak home insecticide performance remain key monitorables. Jefferies has a 'buy' call with a Target Price of ₹1,400, backed by positive management commentary driven by market share gains in home insecticides. The brokerage expects margin strain in India to trickle down to the second quarter but reiterated management's expectations to exceed FY27 consolidated revenue and EBITDA guidance, with management targeting 22-26% India margins in the second half of fiscal 2027.